LINDUS HEALTH
LIVE

Serial Number

98032355

Owner

Lindus Health Ltd.

Attorney

Ryan S. Hilbert

Filing Date

Jun 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LINDUS HEALTH Trademark

Serial Number: 98032355 • Registration: 7700807

LINDUS HEALTH is a trademark filed by Lindus Health Ltd. on June 7, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Lindus Health Ltd. (5 trademarks)

Weston Street
LONDON SE13ER , GB

Entity Type: 99

Trademark Details

Filing Date

June 7, 2023

Registration Date

February 25, 2025

Published for Opposition

May 21, 2024

Goods & Services

Providing independent review of clinical trials for business purposes for the purpose of improving, consulting on, organizing, managing and optimizing clinical trials; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting services in the field of clinical trials; Business advisory services in the field of clinical trials; Business information services in the field of clinical trials; none of the foregoing consisting of marketing, marketing consulting and market research services in the fields of bio- technology and the life sciences

Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes

Platform as a service (PAAS) featuring software for use in collecting, analyzing, processing, tracking, synthesizing, storing, organizing, exchanging, sharing, reporting, transmitting and distributing information, data, images, audio, video and audiovisual materials in the fields of clinical research and clinical trials; Software as a service (SAAS) featuring software for use in collecting, analyzing, processing, tracking, synthesizing, storing, organizing, exchanging, sharing, reporting, transmitting and distributing information, data, images, audio, video and audiovisual materials in the fields of clinical research and clinical trials; Technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with clinical research and clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical trials and studies for others; Providing information in the fields of clinical research and clinical trials via a website

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Feb 3, 2025 TMBN
OPPOSITION TERMINATED NO. 999999
Feb 3, 2025 OP.T
OPPOSITION DISMISSED NO. 999999
Feb 3, 2025 OP.D
POST PUBLICATION AMENDMENT - ENTERED
Sep 30, 2024 CHPB
ASSIGNED TO PETITION STAFF
Sep 30, 2024 APET
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 19, 2024 ETOP
OPPOSITION INSTITUTED NO. 999999
Sep 19, 2024 OP.I
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 17, 2024 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 20, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2024 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 18, 2024 GPRN
PRIORITY ACTION E-MAILED
Mar 18, 2024 GPRA
PRIORITY ACTION WRITTEN
Mar 18, 2024 CPRA
ASSIGNED TO EXAMINER
Feb 27, 2024 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 9, 2024 AMPX
ASSIGNED TO LIE
Feb 9, 2024 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 19, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2023 NWOS
NEW APPLICATION ENTERED
Jun 10, 2023 NWAP